CRBU vs HAL · rev $10.0M vs P/E 9.3, $19.05B cap
Caribou Biosciences Inc (CRBU) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Caribou Biosciences Inc (CRBU) is a biotechnology company listed on US.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported CRBU revenue for 2024-12-31 was $10.0M. Net income was -$149.1M. Revenue was down 71.0% from 2023-12-31 to 2024-12-31. CRBU currently screens at market cap $190.4M.
HAL does not have a complete income-statement cache yet.
CRBU currently screens at market cap $190.4M. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the CRBU and HAL stock pages for the full models.
Not investment advice.